Association of Dysanapsis with FEV1 Decline in Early COPD: The BEACON Cohort

被引:0
|
作者
Ritchie, Andrew [1 ]
Donaldson, Gavin [1 ,2 ]
Hoffman, Eric [3 ,8 ]
Allinson, James [1 ,2 ]
Bloom, Chloe [1 ,2 ]
Smith, Benjamin [4 ]
Bolton, Charlotte [5 ,7 ]
Choudhury, Gourab [4 ,6 ]
Gerard, Sarah [5 ,7 ]
Guo, Junfeng [8 ]
Alves-Moreira, Luana [1 ,2 ]
Mcgarvey, Lorcan [6 ,9 ]
Sapey, Elizabeth [9 ,10 ]
Stockley, Robert [10 ]
Yip, Kp [10 ]
Singh, Dave [11 ]
Wilkinson, Tom [10 ,12 ]
Mullerova, Hana [11 ,13 ]
Ostridge, Kristoffer [14 ]
Joens, Olaf [15 ]
Bucchioni, Enrica [16 ]
Compton, Chris [17 ]
Jones, Paul [17 ]
Mezzi, Karen [16 ,18 ]
Vestbo, Jorgen [11 ]
Calverley, Peter [17 ,19 ]
Wedzicha, Jadwiga [1 ,2 ]
机构
[1] AstraZeneca, Early Clin Dev, R&I, London, England
[2] Imperial Coll London, NHLI, London, England
[3] Univ Iowa, Dept Radiol, Iowa City, IA USA
[4] McGill Univ, Dept Med, Quebec City, PQ, Canada
[5] NIHR Nottingham Biomed Res Ctr, Nottingham, England
[6] Queens Med Res Inst, ELEGI & COLT Labs, 47 Little France Crescent, Edinburgh, Scotland
[7] Univ Iowa, Roy J Carver Dept Biomed Engn, Iowa City, IA USA
[8] Univ Iowa, Dept Radiol, Iowa City, IA USA
[9] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast, North Ireland
[10] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, England
[11] Univ Manchester, Div Infect Immun & Resp Med, Manchester, England
[12] Univ Southampton, Fac Med, Southampton, England
[13] AstraZeneca, Cambridge, England
[14] AstraZeneca, Gothenburg, Sweden
[15] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[16] Chiesi Farmaceut SpA, Parma, Italy
[17] GlaxoSmithKline, Brentford, England
[18] Novartis Pharm AG, Basel, Switzerland
[19] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, England
关键词
D O I
10.1183/13993003.congress-2024.PA3038
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease
    Kim, Jeong-Hyun
    Park, Byung-Lae
    Pasaje, Charisse Flerida A.
    Bae, Joon Seol
    Park, Jong Sook
    Park, Sung Woo
    Uh, Soo-Taek
    Choi, Jae-Sung
    Kim, Yong-Hoon
    Kim, Mi-Kyeong
    Choi, Inseon S.
    Cho, Sang Heon
    Choi, Byoung Whui
    Park, Choon-Sik
    Shin, Hyoung Doo
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (03) : 2385 - 2394
  • [42] COPD: Pulmonary damage beyond FEV1
    Denker, Sebastiaan
    Rudolphus, Arjan
    Roos, Arjen
    In't Veen, Johannes
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [43] FEV1 decline in grain exposed workers
    Moore, V
    Anees, W
    Blainey, D
    Robertson, K
    Burge, PS
    THORAX, 2005, 60 : II73 - II73
  • [44] Rate of Decline in FEV1: Is Emphysema the Culprit?
    Washko, George R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (01) : 2 - 3
  • [45] SMOKING, ALLERGY, AND RATE OF DECLINE IN FEV1
    TAYLOR, RG
    GROSS, E
    JOYCE, H
    HOLLAND, F
    PRIDE, NB
    THORAX, 1984, 39 (09) : 695 - 695
  • [46] A Review of the Role of FEV1 in the COPD Paradigm
    Doherty, Dennis E.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2008, 5 (05) : 310 - 318
  • [47] PREDICTIVE VALUE OF COMBINING RAPID DECLINE OF FEV1 AND INFLAMMATORY BIOMARKERS FOR DEVELOPING COPD-A PROSPECTIVE COHORT STUDY IN BEIJING
    Liao, Jiping
    Zhao, Yanni
    Cheng, Yuan
    Zhang, Cheng
    Wang, Guangfa
    RESPIROLOGY, 2018, 23 : 240 - 240
  • [48] FEV1/FEV6 May Misdiagnose Patients With COPD
    Ruppel, Gregg L.
    Haynes, Jeffrey M.
    Kaminsky, David A.
    RESPIRATORY CARE, 2016, 61 (07) : 999 - 1001
  • [49] Dyspnoea perception and FEV1 decline during Sputum Induction in Healthy Controls and COPD patients
    Rodrigues, Pedro
    Ostridge, Kristoffer
    Staples, Karl
    Gove, Kerry
    Bawden, Sarah
    Wilkinson, Tom
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [50] So inhaled steroids slow the rate of decline of FEV1 in patients with COPD after all?
    Burge, PS
    Lewis, SA
    THORAX, 2003, 58 (11) : 911 - 913